Simian Immunodeficiency Virus Persistence in Cellular and Anatomic Reservoirs in Antiretroviral Therapy-Suppressed Infant Rhesus Macaques. 2018

Maud Mavigner, and Jakob Habib, and Claire Deleage, and Elias Rosen, and Cameron Mattingly, and Katherine Bricker, and Angela Kashuba, and Franck Amblard, and Raymond F Schinazi, and Benton Lawson, and Thomas H Vanderford, and Sherrie Jean, and Joyce Cohen, and Colleen McGary, and Mirko Paiardini, and Matthew P Wood, and Donald L Sodora, and Guido Silvestri, and Jacob Estes, and Ann Chahroudi
Department of Pediatrics and Center for AIDS Research, Emory University School of Medicine, Atlanta, Georgia, USA.

Worldwide, nearly two million children are infected with human immunodeficiency virus (HIV), with breastfeeding accounting for the majority of contemporary HIV transmissions. Antiretroviral therapy (ART) has reduced HIV-related morbidity and mortality but is not curative. The main barrier to a cure is persistence of latent HIV in long-lived reservoirs. However, our understanding of the cellular and anatomic sources of the HIV reservoir during infancy and childhood is limited. Here, we developed a pediatric model of ART suppression in orally simian immunodeficiency virus (SIV)-infected rhesus macaque (RM) infants, with measurement of virus persistence in blood and tissues after 6 to 9 months of ART. Cross-sectional analyses were conducted to compare SIV RNA and DNA levels in adult and infant RMs naive to treatment and on ART. We demonstrate efficient viral suppression following ART initiation in SIV-infected RM infants with sustained undetectable plasma viral loads in the setting of heterogeneous penetration of ART into lymphoid and gastrointestinal tissues and low drug levels in the brain. We further show reduction in SIV RNA and DNA on ART in lymphoid tissues of both infant and adult RMs but stable (albeit low) levels of SIV RNA and DNA in the brains of viremic and ART-suppressed infants. Finally, we report a large contribution of naive CD4+ T cells to the total CD4 reservoir of SIV in blood and lymph nodes of ART-suppressed RM infants that differs from what we show in adults. These results reveal important aspects of HIV/SIV persistence in infants and provide insight into strategic targets for cure interventions in a pediatric population.IMPORTANCE While antiretroviral therapy (ART) can reduce HIV replication, the virus cannot be eradicated from an infected individual, and our incomplete understanding of HIV persistence in reservoirs greatly complicates the generation of a cure for HIV infection. Given the immaturity of the infant immune system, it is critically important to study HIV reservoirs specifically in this population. Here, we established a pediatric animal model to simulate breastfeeding transmission and study SIV reservoirs in rhesus macaque (RM) infants. Our study demonstrates that ART can be safely administered to infant RMs for prolonged periods and that it efficiently controls viral replication in this model. SIV persistence was shown in blood and tissues, with similar anatomic distributions of SIV reservoirs in infant and adult RMs. However, in the peripheral blood and lymph nodes, a greater contribution of the naive CD4+ T cells to the SIV reservoir was observed in infants than in adults.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004197 Disease Reservoirs Animate or inanimate sources which normally harbor disease-causing organisms and thus serve as potential sources of disease outbreaks. Reservoirs are distinguished from vectors (DISEASE VECTORS) and carriers, which are agents of disease transmission rather than continuing sources of potential disease outbreaks. Humans may serve both as disease reservoirs and carriers. Disease Reservoir,Human Disease Reservoirs,Infectious Disease Reservoir,Reservoirs of Infection,Infectious Disease Reservoirs,Disease Reservoir, Human,Disease Reservoir, Infectious,Disease Reservoirs, Human,Human Disease Reservoir,Infection Reservoir,Infection Reservoirs,Reservoir, Disease,Reservoir, Infectious Disease,Reservoirs, Human Disease
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015302 Simian Immunodeficiency Virus Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV. SIV (Simian immunodeficiency virus),Immunodeficiency Viruses, Simian,Simian Immunodeficiency Viruses,Immunodeficiency Virus, Simian
D016097 Simian Acquired Immunodeficiency Syndrome Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS; (MPMV), or in monkeys infected with SIMIAN IMMUNODEFICIENCY VIRUS. AIDS, Simian,SAIDS,Simian AIDS,Simian Acquired Immune Deficiency Syndrome,Simian Acquired Immuno-Deficiency Syndrome,AIDSs, Simian,Simian AIDSs,Simian Acquired Immuno Deficiency Syndrome
D018445 Infectious Disease Transmission, Vertical The transmission of infectious disease or pathogens from one generation to another. It includes transmission in utero or intrapartum by exposure to blood and secretions, and postpartum exposure via breastfeeding. Fetomaternal Infection Transmission,Infection Transmission, Fetomaternal,Infection Transmission, Maternal-Fetal,Infection Transmission, Vertical,Maternal-Fetal Infection Transmission,Mother-to-Child Transmission,Pathogen Transmission, Vertical,Vertical Infection Transmission,Vertical Infectious Disease Transmission,Vertical Transmission of Infectious Disease,Infection Transmission, Maternal Fetal,Maternal Fetal Infection Transmission,Mother to Child Transmission,Mother-to-Child Transmissions,Transmission, Fetomaternal Infection,Transmission, Maternal-Fetal Infection,Transmission, Mother-to-Child,Transmission, Vertical Infection,Transmission, Vertical Pathogen,Transmissions, Mother-to-Child,Vertical Pathogen Transmission
D018791 CD4 Lymphocyte Count The number of CD4-POSITIVE T-LYMPHOCYTES per unit volume of BLOOD. Determination requires the use of a fluorescence-activated flow cytometer. Lymphocyte Count, CD4,T4 Lymphocyte Count,CD4 Cell Counts,CD4 Counts,CD4+ Cell Counts,CD4+ Counts,CD4 Cell Count,CD4 Count,CD4 Lymphocyte Counts,CD4+ Cell Count,CD4+ Count,Count, T4 Lymphocyte,Counts, T4 Lymphocyte,Lymphocyte Count, T4,Lymphocyte Counts, CD4,Lymphocyte Counts, T4,T4 Lymphocyte Counts
D019562 Viral Load The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression. Viral Burden,Virus Titer,Burden, Viral,Load, Viral,Titer, Virus

Related Publications

Maud Mavigner, and Jakob Habib, and Claire Deleage, and Elias Rosen, and Cameron Mattingly, and Katherine Bricker, and Angela Kashuba, and Franck Amblard, and Raymond F Schinazi, and Benton Lawson, and Thomas H Vanderford, and Sherrie Jean, and Joyce Cohen, and Colleen McGary, and Mirko Paiardini, and Matthew P Wood, and Donald L Sodora, and Guido Silvestri, and Jacob Estes, and Ann Chahroudi
January 2017, AIDS (London, England),
Maud Mavigner, and Jakob Habib, and Claire Deleage, and Elias Rosen, and Cameron Mattingly, and Katherine Bricker, and Angela Kashuba, and Franck Amblard, and Raymond F Schinazi, and Benton Lawson, and Thomas H Vanderford, and Sherrie Jean, and Joyce Cohen, and Colleen McGary, and Mirko Paiardini, and Matthew P Wood, and Donald L Sodora, and Guido Silvestri, and Jacob Estes, and Ann Chahroudi
November 2013, AIDS research and human retroviruses,
Maud Mavigner, and Jakob Habib, and Claire Deleage, and Elias Rosen, and Cameron Mattingly, and Katherine Bricker, and Angela Kashuba, and Franck Amblard, and Raymond F Schinazi, and Benton Lawson, and Thomas H Vanderford, and Sherrie Jean, and Joyce Cohen, and Colleen McGary, and Mirko Paiardini, and Matthew P Wood, and Donald L Sodora, and Guido Silvestri, and Jacob Estes, and Ann Chahroudi
August 2019, Journal of virology,
Maud Mavigner, and Jakob Habib, and Claire Deleage, and Elias Rosen, and Cameron Mattingly, and Katherine Bricker, and Angela Kashuba, and Franck Amblard, and Raymond F Schinazi, and Benton Lawson, and Thomas H Vanderford, and Sherrie Jean, and Joyce Cohen, and Colleen McGary, and Mirko Paiardini, and Matthew P Wood, and Donald L Sodora, and Guido Silvestri, and Jacob Estes, and Ann Chahroudi
May 2022, The Journal of clinical investigation,
Maud Mavigner, and Jakob Habib, and Claire Deleage, and Elias Rosen, and Cameron Mattingly, and Katherine Bricker, and Angela Kashuba, and Franck Amblard, and Raymond F Schinazi, and Benton Lawson, and Thomas H Vanderford, and Sherrie Jean, and Joyce Cohen, and Colleen McGary, and Mirko Paiardini, and Matthew P Wood, and Donald L Sodora, and Guido Silvestri, and Jacob Estes, and Ann Chahroudi
April 2021, Journal of virology,
Maud Mavigner, and Jakob Habib, and Claire Deleage, and Elias Rosen, and Cameron Mattingly, and Katherine Bricker, and Angela Kashuba, and Franck Amblard, and Raymond F Schinazi, and Benton Lawson, and Thomas H Vanderford, and Sherrie Jean, and Joyce Cohen, and Colleen McGary, and Mirko Paiardini, and Matthew P Wood, and Donald L Sodora, and Guido Silvestri, and Jacob Estes, and Ann Chahroudi
August 2017, mBio,
Maud Mavigner, and Jakob Habib, and Claire Deleage, and Elias Rosen, and Cameron Mattingly, and Katherine Bricker, and Angela Kashuba, and Franck Amblard, and Raymond F Schinazi, and Benton Lawson, and Thomas H Vanderford, and Sherrie Jean, and Joyce Cohen, and Colleen McGary, and Mirko Paiardini, and Matthew P Wood, and Donald L Sodora, and Guido Silvestri, and Jacob Estes, and Ann Chahroudi
October 2020, Journal of virology,
Maud Mavigner, and Jakob Habib, and Claire Deleage, and Elias Rosen, and Cameron Mattingly, and Katherine Bricker, and Angela Kashuba, and Franck Amblard, and Raymond F Schinazi, and Benton Lawson, and Thomas H Vanderford, and Sherrie Jean, and Joyce Cohen, and Colleen McGary, and Mirko Paiardini, and Matthew P Wood, and Donald L Sodora, and Guido Silvestri, and Jacob Estes, and Ann Chahroudi
November 1996, Antimicrobial agents and chemotherapy,
Maud Mavigner, and Jakob Habib, and Claire Deleage, and Elias Rosen, and Cameron Mattingly, and Katherine Bricker, and Angela Kashuba, and Franck Amblard, and Raymond F Schinazi, and Benton Lawson, and Thomas H Vanderford, and Sherrie Jean, and Joyce Cohen, and Colleen McGary, and Mirko Paiardini, and Matthew P Wood, and Donald L Sodora, and Guido Silvestri, and Jacob Estes, and Ann Chahroudi
December 2021, AIDS (London, England),
Maud Mavigner, and Jakob Habib, and Claire Deleage, and Elias Rosen, and Cameron Mattingly, and Katherine Bricker, and Angela Kashuba, and Franck Amblard, and Raymond F Schinazi, and Benton Lawson, and Thomas H Vanderford, and Sherrie Jean, and Joyce Cohen, and Colleen McGary, and Mirko Paiardini, and Matthew P Wood, and Donald L Sodora, and Guido Silvestri, and Jacob Estes, and Ann Chahroudi
October 1999, The American journal of pathology,
Copied contents to your clipboard!